These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 23267885

  • 1. [Two cases of long-term survival of metastatic colorectal cancer following treatment with polysaccharide K and mFOLFOX6 therapy].
    Ohta K, Matsui S, Sato Y, Murao S.
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1782-4. PubMed ID: 23267885
    [Abstract] [Full Text] [Related]

  • 2. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.
    Mori Y, Nishimura T, Kitano T, Yoshimura K, Matsumoto S, Kanai M, Hazama M, Ishiguro H, Nagayama S, Yanagihara K, Teramukai S, Chiba T, Sakai Y, Fukushima M.
    Oncology; 2010 Nov; 79(1-2):136-43. PubMed ID: 21150228
    [Abstract] [Full Text] [Related]

  • 3. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]

  • 4. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y, Kato T, Shimizu Y, Inaba Y, Shimada Y, Nakamura K, Sato A, Moriya Y, Colorectal Cancer Study Group (CCSG) of Japan Clinical Oncology Group.
    Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
    [Abstract] [Full Text] [Related]

  • 5. Metastatic colorectal cancer: is surgery necessary?
    Schmidt C.
    J Natl Cancer Inst; 2009 Aug 19; 101(16):1113-5. PubMed ID: 19671774
    [No Abstract] [Full Text] [Related]

  • 6. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
    Taïeb J, Artru P, Paye F, Louvet C, Perez N, André T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R, de Gramont A.
    J Clin Oncol; 2005 Jan 20; 23(3):502-9. PubMed ID: 15659495
    [Abstract] [Full Text] [Related]

  • 7. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
    Sugimoto M, Yasuda H, Koda K, Yamazaki M, Tezuka T, Takenoue T, Kosugi C, Higuchi R, Yamamoto S, Watayo Y, Yagawa Y, Suzuki M.
    Hepatogastroenterology; 2007 Sep 20; 54(78):1684-8. PubMed ID: 18019695
    [Abstract] [Full Text] [Related]

  • 8. [Therapeutic effect of mFOLFOX6 for synchronous unresectable liver metastases from colorectal cancer].
    Chikatani K, Ishibashi K, Tajima Y, Hatano S, Amano K, Ishiguro T, Kuwabara K, Sobajima J, Ohsawa T, Okada N, Kumamoto K, Haga N, Iwama T, Ishida H.
    Gan To Kagaku Ryoho; 2011 Nov 20; 38(12):2211-3. PubMed ID: 22202333
    [Abstract] [Full Text] [Related]

  • 9. [The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis].
    Honjou H, Ishibashi K, Okada N, Tajima Y, Ishiguro T, Kuwabara K, Ohsawa T, Kumamoto K, Tsuji Y, Haga N, Iwama T, Ishida H.
    Gan To Kagaku Ryoho; 2011 Nov 20; 38(12):2216-9. PubMed ID: 22202335
    [Abstract] [Full Text] [Related]

  • 10. [End results of combined treatment in metastatic colorectal cancer].
    Polysalov VN, Rutkin IO, Krotova OA, Tlostanova MS.
    Vopr Onkol; 2011 Nov 20; 57(2):265-9. PubMed ID: 21809678
    [No Abstract] [Full Text] [Related]

  • 11. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M, gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
    J Clin Oncol; 2005 Aug 01; 23(22):4881-7. PubMed ID: 16009952
    [Abstract] [Full Text] [Related]

  • 12. Surgical therapies in metastatic colorectal cancer with a potential for cure.
    Chua TC, Liauw W, Koong HN, Esquivel J.
    Am J Clin Oncol; 2011 Jun 01; 34(3):326-31. PubMed ID: 20498587
    [Abstract] [Full Text] [Related]

  • 13. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K, Munakata M, Muto O, Kasai M, Okada R, Mitobe S, Sakata Y.
    Gan To Kagaku Ryoho; 2007 Jul 01; 34(7):1079-84. PubMed ID: 17637544
    [Abstract] [Full Text] [Related]

  • 14. [PSK decreased FOLFOX4-induced peripheral neuropathy and bone marrow suppression in patients with metastatic colorectal cancer].
    Shibata M, Shimura T, Nishina Y, Gonda K, Matsuo S, Abe H, Yajima Y, Nakamura I, Ohki S, Takenoshita S.
    Gan To Kagaku Ryoho; 2011 May 01; 38(5):797-801. PubMed ID: 21566440
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.
    Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, Brunetti IM, Ferraldeschi R, Naso G, Filipponi F, Pietrabissa A, Goletti O, Baldi G, Fornaro L, Andreuccetti M, Falcone A.
    Ann Surg; 2009 Mar 01; 249(3):420-5. PubMed ID: 19247029
    [Abstract] [Full Text] [Related]

  • 16. [Clinical administration of FOLFOX regimens for patients with unresectable advanced or recurrent colorectal cancer].
    Minami K, Kameda A, Tsutani Y, Suzuki T, Miyahara E, Noso Y.
    Gan To Kagaku Ryoho; 2007 Apr 01; 34(4):573-7. PubMed ID: 17431362
    [Abstract] [Full Text] [Related]

  • 17. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
    Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH.
    J Clin Oncol; 2005 Dec 20; 23(36):9243-9. PubMed ID: 16230673
    [Abstract] [Full Text] [Related]

  • 18. [IFL].
    Yamazaki K, Yoshino T, Boku N.
    Gan To Kagaku Ryoho; 2006 Jul 20; 33(7):907-10. PubMed ID: 16835478
    [Abstract] [Full Text] [Related]

  • 19. Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.
    Benavides M, Pericay C, Valladares-Ayerbes M, Gil-Calle S, Massutí B, Aparicio J, Dueñas R, González-Flores E, Carrato A, Marcuello E, Gómez A, Cabrera E, Queralt B, Gómez MJ, Guasch I, Etxeberría A, Alfaro J, Campos JM, Reina JJ, Aranda E.
    Clin Colorectal Cancer; 2012 Sep 20; 11(3):200-6. PubMed ID: 22421001
    [Abstract] [Full Text] [Related]

  • 20. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006 Sep 20; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.